Yellow fever is an acute viral haemorrhagic disease caused by the virus of the Flavivirus family. It is primarily transmitted to humans and other primates through the bite of Aedes and Haemagogus species of mosquitoes. The yellow in the name refers to the jaundice that affects some infected individuals due to acute liver failure (WHO, 2017). Sporadic cases have been reported in rural areas but when introduced to urban communities, it can cause large epidemics. (WHO, 2013)
About 88% of cases are asymptomatic, 9–10% will present with fever only while 2–3% will present with fever and jaundice (acute liver failure) or haemorrhage (WHO, 2017). Symptoms can vary from mild symptoms that subside within few days to severe symptoms such as high fever, jaundice, abdominal pain, vomiting and bleeding from body orifices. The mortality rate in individuals with severe symptoms can be as high as 50% (Garske et al., 2014)
Diagnosis is by Polymerase chain reaction, Enzyme linked immunosorbent assay or Sero-neutralization. (WHO 2017). There is no specific treatment for yellow fever. Symptomatic, supportive treatment and treatment of associated conditions/secondary infections is given to infected individuals. During an outbreak, reactive vaccination, community mobilisation, vector control, active case search and case management are the prioritized control measures. (WHO, 2017). The epidemic threshold is a single case of yellow fever.
The global strategy to eliminate yellow fever epidemics (EYE) is a multi-component and multi-partner strategy with a 10-year target – 2017–2026. The components include protection of at-risk populations, prevention of international spread and rapid containment of outbreaks. (WHO, 2017). Routine immunization activities are organised for children below the age of 1 year to prevent yellow fever among them.
The World Health Organization (WHO) estimates that globally, 84,000–170,000 severe cases of yellow fever occur with about 60,000 deaths annually. More than 90% of all cases of yellow fever occur in Africa (Krishna, 2017) (WHO, 2017).
Many African countries and regions have reported series of yellow fever outbreaks over the past years (Muanya, 2016). In December 2015, Angola reported a large outbreak of yellow fever, 6890 cases were reported with 492 deaths (WHO, 2016). The Angola outbreak spread to the Democratic Republic of Congo (DCR) and China making the first yellow fever outbreak in China.
Nigeria has recorded series of yellow fever outbreaks. The earliest yellow fever outbreak in Nigeria was reported in Lagos in 1864. Other outbreaks of yellow fever occurred in Lagos in 1894, 1905, 1906, 1925 and 1926 (Nwachukwu William et al., 2022). A large outbreak of yellow fever occurred in Jos in 1969 which spread to other parts of the country. Over 100,000 people were infected. Over 120,000 individuals were infected with yellow fever in Cross river, Plateau, Benue and Oyo States between 1987 and 1996. (WHO, 2021). Nigeria did not report any case from 1996 to 2016, thus the World Health Organisation (WHO) was planning to declare Nigeria yellow fever free.
However, after 21 years of recording no confirmed case of yellow fever in Nigeria, a case was detected in Ifelodun Local Government Area of Kwara State in 2017. (NCDC, 2020). The case was a 7-year-old nomadic Fulani who presented with fever and yellowness of the eyes. (NCDC, 2020). Immediately, the rapid response team (RRT) of the Nigerian Centre for Disease Control (NCDC) conducted yellow fever vaccination campaign for children less than 10 years. Active case search and evaluation of immunization records of children within this age range was conducted in addition to other response activities like risk communication and social mobilization. In December, 2018 another case of yellow fever was confirmed in Ifelodun Local Government Area of Kwara State. The response was carried out by the Kwara State Ministry of Health. (Awoyale et al., 2021)
Yellow fever can produce large outbreaks with a risk of international spread. It is a potential cause of public health emergencies of international concern that threaten the global public health security. More than 25 of the 54 African Countries including Nigeria are at high risk of the yellow fever, necessitating an improved preparedness.
Large outbreaks of yellow fever were reported in Angola and DRC which highlighted the gaps in preparedness, surveillance, and rapid diagnosis. In addition, factors like porous borders and increased migration, the widespread distribution of Aedes mosquitoes and lack of efficient health preparedness and surveillance system, favour this complex epidemiological scenario of re-emergence of yellow fever. (Ortiz-Martínez et al., 2017).
Yellow fever continues to cause several morbidity and mortality in Africa despite the availability of an effective vaccine for more than 70 years. This has been attributed to the sub-optimal level of preparedness (Nomhwange et al., 2021)(Fatiregun et al., 2021). Nigeria is considered as one of the high-risk countries for yellow fever in Africa. Nigeria has the highest burden of yellow fever primarily due to her large population size, high vulnerability to infections, the low rate of vaccination uptake and sub-optimal preparedness (Chime et al., 2021).
According to Centres for Disease Control and Prevention (CDC), yellow fever virus is estimated to cause 200,000 cases of disease and 30,000 deaths globally each year. On the average 84,000–170,000 severe cases of yellow fever occur with about 60,000 deaths annually. More than 90% of all cases of yellow fever occur in Africa (Krishna, 2017)(WHO, 2017). The mortality rate ranged from 0.1/100,000 in Nigeria to 2200/100,000 in Ghana while the case fatality rate associated with yellow fever outbreaks ranged from 10% in Ghana to 86% in Nigeria. The high case fatality rate associated with yellow fever outbreaks in Nigeria can be linked to the low level of preparedness (Nwaiwu et al., 2021).
It has been estimated that 20–50% of infected persons who develop severe disease die; however earlier detection and treatment has been shown to reduce mortality among the infected (WHO, 2017). This highlights the need for preparedness for the outbreak by health workers and health authorities.
Yellow fever preparedness is a proactive measure. The efficiency of the response mounted against the Ebola Virus Disease (EVD) outbreak of 2014 proved that indeed, though challenging, proactive, and effective outbreak response is possible. (WHO, 2016)
According to the World Health Organisation (WHO), Nigeria is one of only five members of the WHO African Region to report at least five public health events per annum. Over 20 public health emergencies and infectious disease outbreaks including yellow fever were reported from Nigeria between 2016 and 2018 alone. (WHO, 2019). Future pandemic preparedness is therefore essential if we are to find better solutions to potential outbreaks of either known or novel pathogens and to save future lives (Williams, Nicola. 2023).
The emergence of yellow fever outbreak in Kwara State, Nigeria after 21 years of not reporting any case of yellow fever affirms reports from other countries on the African continent that yellow fever is a re-emerging public health disease. (Nwachukwu William et al., 2022). Yellow fever can spread from one country to another. Kwara State shares boundary with the Republic of Benin that is also at a high risk of yellow fever outbreak. This raises the issue of the potential pandemic threat of yellow fever as it may spread across the border. Therefore, Studying the yellow fever epidemic preparedness of health care workers in Kwara State is crucial.
The importance of epidemic preparedness is illustrated in the study by (Kellerborg et al., 2020) in Sierra Leone in which it was found that 10,257 cases of Ebola virus disease and 8,835 deaths would have been averted if the interventions were four weeks earlier. Outbreaks of vaccine-preventable infectious diseases, such as meningococcal disease, yellow fever, and cholera, can have disastrous effects in areas with limited health infrastructure and resources, and where timely detection and response is difficult (WHO, 2023).
Preparedness for one epidemic will help in the response to another epidemic. Ebola response helped the response to COVID-19 (Olumade et al., 2020). In addition, the lessons from the Spanish flu of the 1820s also helped with the response to COVID-19 but there is also need to prepare specifically for epidemic of a defined disease because response to epidemic may differ by the disease aetiology (WHO, 2019)
Prompt detection of yellow fever and rapid response through emergency vaccination campaigns are essential for controlling outbreaks. (WHO, 2019). There is limited record of capacity assessment of the epidemic preparedness for yellow fever. However, a study conducted in Nigeria revealed that there is no formal document clearly outlining the coordination between the NCDC, the FMOH, parastatal agencies and partners at the national, State and LGA levels in terms of emergency preparedness and response (Oboma Eteng et al., 2022)
In 2017, WHO developed the Eliminating yellow fever Epidemic (EYE) strategy to improve high risk country preparedness for surveillance, detection, and response. Gaps and challenges in yellow fever preparedness therefore need to be identified and addressed to forestall the re-emergence of the yellow fever outbreak in Kwara State.
This study therefore aimed to assess the knowledge and self-efficacy of healthcare workers in detecting and reporting yellow fever in Kwara State.